Date | Insider | Price | Amount |
---|---|---|---|
6-6-2022 Insider Buy |
Richard Aldrich Director |
$4.75 CAGR » |
$999,998.50 210,526 shares |
6-6-2022 Insider Buy |
Thomas G. Auchincloss Director |
$4.75 CAGR » |
$28,500.00 6,000 shares |
6-6-2022 Insider Buy |
Christi Van Heek Director |
$4.75 CAGR » |
$49,998.50 10,526 shares |
3-12-2020 Insider Buy |
Thomas G. Auchincloss Director |
$8.52 CAGR » |
$12,772.50 1,500 shares |
2-3-2020 Insider Buy |
Thomas G. Auchincloss Director |
$10.91 CAGR » |
$10,910.00 1,000 shares |
10-8-2019 Insider Buy |
Christi Van Heek Director |
$8.37 CAGR » |
$83,706.50 10,000 shares |
11-15-2018 Insider Buy |
Thomas G. Auchincloss Director |
$11.50 CAGR » |
$11,500.00 1,000 shares |
11-15-2018 Insider Buy |
Richard Aldrich Director |
$11.83 CAGR » |
$591,262.00 50,000 shares |
11-14-2018 Insider Buy |
Thomas G. Auchincloss Director |
$11.93 CAGR » |
$11,931.40 1,000 shares |
10-19-2017 Insider Buy |
Partners L. P/IL Bvf >10% Owner |
$15.84 CAGR » |
$5,256,719.65 331,916 shares |
5-12-2016 Insider Buy |
Thomas G. Auchincloss Director |
$10.11 CAGR » |
$20,211.20 2,000 shares |
2-20-2014 Insider Buy |
Venture Partners Qualified Purchaser Fund L. P. Skyline IV >10% Owner |
$14.00 CAGR » |
$2,100,000.00 150,000 shares |
2-20-2014 Insider Buy |
John Gordon Freund Director and >10% Owner |
$14.00 CAGR » |
$2,100,000.00 150,000 shares |
2-19-2014 Insider Buy |
BROOKSIDE CAPITAL MANAGEMENT LLC >10% Owner |
$14.00 CAGR » |
$4,900,000.00 350,000 shares |
2-19-2014 Insider Buy |
THREE ARCH MANAGEMENT III LLC Director and >10% Owner |
$14.00 CAGR » |
$1,449,000.00 103,500 shares |
2-19-2014 Insider Buy |
Arch Management Iv, L.L.C. Three Director and >10% Owner |
$14.00 CAGR » |
$1,449,000.00 103,500 shares |
2-19-2014 Insider Buy |
QVT Associates GP LLC >10% Owner |
$14.00 CAGR » |
$4,200,000.00 300,000 shares |
2-19-2014 Insider Buy |
Plc Glaxosmithkline |
$14.00 CAGR » |
$490,000.00 35,000 shares |
2-19-2014 Insider Buy |
Life Science Ventures VI Gmbh & Co KG Tvm Director and >10% Owner |
$14.00 CAGR » |
$1,246,000.00 89,000 shares |
Also See: Institutional Holders of CNCE
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 06/07/2022 | |
End date: | 03/06/2023 | |
Start price/share: | $4.91 | |
End price/share: | $8.37 | |
Dividends collected/share: | $0.00 | |
Total return: | 70.47% | |
Annualized Gain: | 94.56% | |
Starting investment: | $10,000.00 | |
Ending investment: | $17,047.00 | |
Years: | 0.75 |
CNCE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CNCE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CNCE
Free CNCE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the CNCE Insider Buying occurred are:
AIV Insider Buying |